Potentiation of 1,25-dihydroxyvitamin D3-induced differentiation of human promyelocytic leukemia cells into monocytes by costunolide, a germacranolide sesquiterpene lactone

Biochemical Pharmacology

Volumn 64, Issue 8, 2002, Pages 1233-1242

  Kim, Seung H ^a   Kang, So N ^a   Kim, Hyeoung J ^b   Kim, Tae S ^a,b  

^a Chonnam National University   (South Korea)

^b Chonnam National University Medical School   (South Korea)

Author keywords

1,25 Dihydroxyvitamin D3; Cell differentiation; Costunolide; Extracellular signal regulated kinase; Nuclear factor B; Protein kinase C

Indexed keywords

CALCITRIOL; COSTUNOLIDE; GERMACRANOLIDE DERIVATIVE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LACTONE; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN; PROTEIN 13K; PROTEIN KINASE C; UNCLASSIFIED DRUG;

ARTICLE; CARCINOGENESIS; CELL CULTURE; CELL DIFFERENTIATION; CELL STRAIN HL 60; CELL STRUCTURE; CONTROLLED STUDY; CYTOFLUOROMETRY; DRUG EFFECT; DRUG POTENTIATION; HUMAN; HUMAN CELL; LEUKEMIA CELL; MEDICINAL PLANT; MONOCYTE; PRIORITY JOURNAL; PROMYELOCYTE; PROMYELOCYTIC LEUKEMIA;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CALCITRIOL; CALCIUM CHANNEL AGONISTS; CELL DIFFERENTIATION; DRUG SYNERGISM; ENZYME INHIBITORS; HL-60 CELLS; HUMANS; LEUKEMIA, MYELOID; MITOGEN-ACTIVATED PROTEIN KINASES; MONOCYTES; NF-KAPPA B; PROTEIN KINASE C; SESQUITERPENES; TUMOR CELLS, CULTURED;

EID: 0037107596     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(02)01292-3     Document Type: Article

References (52)

1. Beere H.M., Hickman J.A. Differentiation: a suitable strategy for cancer chemotherapy? Anti-Cancer Drug Design. 8:1993;299-322.
2. Breitman T.R., Selonick S.E., Collins S.J. Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. Proc. Natl. Acad. Sci. USA. 77:1980;2936-2940.
3. 3 induces differentiation of human promyelocytic leukemia cells (HL-60) into monocytic macrophage, but not into granulocytes. Biochem. Biophys. Res. Commun. 117:1983;86-92.
4. 3 regulation of protein kinase C levels and activity. Biochem. Pharmacol. 54:1997;909-915.
5. Marcinkowska E. Evidence that activation of MEK 1,2/erk 1,2 signal transduction pathway is necessary for calcitriol-induced differentiation of HL-60 cells. Anticancer Res. 21(1A):2001;499-504.
6. Marcinkowska E., Wiedlocha A., Radzikowski C. Evidence that phosphatidylinositol 3-kinase and p70S6K protein are involved in differentiation of HL-60 cells induced by calcitriol. Anticancer Res. 18:1998;3507-3514.
7. 3-induced myeloid cell differentiation is regulated by a vitamin D receptor-phosphatidylinositol 3-kinase signaling complex. J. Exp. Med. 190:1999;1583-1594.
8. 3. Oncol. Res. 9:1997;31-39.
9. 3. Cancer Lett. 125:1998;157-164.
10. Mori H., Kawamori T., Tanaka T., Ohnishi M., Yamahara J. Chemopreventive effect of costunolide, a constituent of oriental medicine, on azoxymethane-induced intestinal carcinogenesis in rats. Cancer Lett. 83:1994;171-175.
11. Kawamori T., Tanaka T., Hara A., Yamahara J., Mori H. Modifying effects of naturally occurring products on the development of colonic aberrant crypt foci induced by azoxymethane in F344 rats. Cancer Res. 55:1995;1277-1282.
12. Ohnishi M., Yoshimi N., Kawamori T., Ino N., Hirose Y., Tanaka T., Yamahara J., Miyata H., Mori H. Inhibitory effects of dietary protocatechuic acid and costunolide on 7,12-dimethylbenz[a]anthracene-induced hamster cheek pouch carcinogenesis. Jpn. J. Cancer Res. 88:1997;111-119.
13. Hehner S.P., Hofmann T.G., Droge W., Schmitz M.L. The antiinflammatory sesquiterpene lactone parthenolide inhibits NF-κB by targeting the IκB kinase complex. J. Immunol. 163:1999;5617-5623.
14. Hall I.H., Williams W.L. Jr., Grippo A.A., Lee K.H., Holbrook D.J., Chaney S.G. Inhibition of nucleic acid synthesis in P-388 lymphocytic leukemia cells in culture by sesquiterpene lactones. Anticancer Res. 8:1988;33-42.
15. Ross J.J., Arnason J.T., Birnboim H.C. Low concentrations of the feverfew component parthenolide inhibit in vitro growth of tumor lines in a cytostatic fashion. Planta Med. 65:1999;126-129.
16. Lee M.G., Lee K.T., Chi S.G., Park J.H. Costunolide induces apoptosis by ROS-mediated mitochondrial permeability transition and cytochrome C release. Biol. Pharm. Bull. 24:2001;303-306.
17. el-Feraly F.S., Chan Y.M. Isolation and characterization of the sesquiterpene lactones costunolide, parthenolide, costunolide diepoxide, santamarine, and reynosin from Magnolia grandiflora L. J. Pharm. Sci. 67:1978;347-350.
18. Park S.H., Choi S.U., Lee C.O., Yoo S.E., Yoon S.K., Kim Y.K., Ryu S.Y. Costunolide, a sesquiterpene from the stem bark of Magnolia sieboldii, inhibits the RAS-farnesyl-protein transferase. Planta Med. 67:2001;358-359.
19. Park H.J., Jung W.T., Basnet P., Kadota S., Namba T. Syringin 4-O-β-glucoside, a new phenylpropanoid glycoside, and costunolide, a nitric oxide synthase inhibitor, from the stem bark of Magnolia sieboldii. J. Nat. Prod. 59:1996;1128-1130.
20. Castro V., Murillo R., Klaas C.A., Meunier C., Mora G., Pahl H.L., Merfort I. Inhibition of the transcription factor NF-κB by sesquiterpene lactones from Podachaenium eminens. Planta Med. 66:2000;591-595.
21. Chen H.C., Chou C.K., Lee S.D., Wang J.C., Yeh S.F. Active compounds from Saussurea lappa Clarks that suppress hepatitis B virus surface antigen gene expression in human hepatoma cells. Antiviral. Res. 27:1995;99-109.
22. Fischer N.H., Lu T., Cantrell C.L., Castaneda-Acosta J., Quijano L., Franzblau S.G. Antimycobacterial evaluation of germacranolides. Phytochemistry. 49:1998;559-564.
23. Wedge D.E., Galindo J.C., Macias F.A. Fungicidal activity of natural and synthetic sesquiterpene lactone analogs. Phytochemistry. 53:2000;747-757.
24. Taniguchi M., Kataoka T., Suzuki H., Uramoto M., Ando M., Arao K., Magae J., Nishimura T., Otake N., Nagai K. Costunolide and dehydrocostus lactone as inhibitors of killing function of cytotoxic T lymphocytes. Biosci. Biotechnol. Biochem. 59:1995;2064-2067.
25. Orfanos C.E., Ehlert R., Gollnick H. The retinoids: a review of their clinical pharmacology and therapeutic use. Drugs. 34:1987;459-503.
26. Coligan JE, Kruisbeck AM, Margulies DH, Shevach EM, Strober W. Current Protocols in Immunology. New York: Wiley; 1995.
27. Collins S.J., Ruscetti F.W., Gallagher R.E., Gallo R.C. Normal functional characteristics of cultured human promyelocytic leukemia cells (HL-60) after induction of differentiation by dimethylsulfoxide. J. Exp. Med. 149:1979;969-974.
28. + T cells from the Th1 to the Th2 pathway. Br. J. Pharmacol. 134:2001;571-578.
29. Chung S.W., Kang B.Y., Kim S.H., Pak Y.K., Cho D., Trinchieri G., Kim T.S. Oxidized low density lipoprotein inhibits interleukin-12 production in lipopolysaccharide-activated mouse macrophages via direct interactions between peroxisome proliferator-activated receptor-γ and nuclear factor-κB. J. Biol. Chem. 275:2000;32681-32687.
30. Wright S.D., Ramos R.A., Tobias P.S., Ulevitch R.J., Mathison J.C. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science. 249:1990;1431-1433.
31. Martell R.E., Simpson R.U., Hsu T. Effects of protein kinase inhibitors 1(5-isoquinolinesulfonyl)-2-methylpiperazine dihydrochloride (H7) and N-[2-quanidinoethyl]-5-isoquinolinesulfonamide hydrochloride (HA1004) on calcitriol-induced differentiation of HL-60 cells. Biochem. Pharmacol. 37:1988;635-640.
32. Wu X.Z., Shao G.Y., Chen S., Wang X.W., Wang Z.Y. Studies on the relationship between protein kinase C and differentiation of human promyelocytic leukemia cells induced by retinoic acid. Leuk. Res. 13:1989;869-874.
33. Bertagnolo V., Neri L.M., Marchisio M., Mischiati C., Capitani S. Phosphoinositide 3-kinase activity is essential for all-trans-retinoic acid-induced granulocytic differentiation of HL-60 cells. Cancer Res. 59:1999;542-546.
34. 3 induced activation and subsequent nuclear translocation of MAPK is upstream regulated by PKC in HL-60 cells. Biochem. Biophys. Res. Commun. 241:1997;419-426.
35. Alessi D.R., Cuenda A., Cohen P., Dudley D.T., Saltiel A.R. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase in vitro and in vivo. J. Biol. Chem. 270:1995;27489-27494.
36. Koo T.H., Lee J.H., Park Y.J., Hong Y.S., Kim H.S., Kim K.W., Lee J.J. A sesquiterpene lactone, costunolide, from Magnolia grandiflora inhibits NF-κB by targeting I kappa B phosphorylation. Planta Med. 67:2001;103-107.
37. 3 and sodium butyrate combination on differentiation and proliferation of HL-60 leukemia cells. Anticancer Res. 12:1992;1947-1952.
38. Kang S.N., Lee M.H., Kim K.-M., Cho D., Kim T.S. Induction of human promyelocytic leukemia HL-60 cell differentiation into monocytes by silibinin: involvement of protein kinase C. Biochem. Pharmacol. 61:2001;1487-1495.
39. Kang S.N., Chung S.W., Kim T.S. Capsaicin potentiates 1,25-dihydroxyvitamin D3- and all-trans retinoic acid-induced differentiation of human promyelocytic leukemia HL-60 cells. Eur. J. Pharmacol. 420:2001;83-90.
40. 3 and tumor necrosis factor α Exp. Hematol. 19:1991;1025-1030.
41. 3 for growth inhibition and differentiation induction of human myelomonocytic leukemia cells by tretinoin tocoferil, a α-tocopherol ester of all-trans retinoic acid. Blood. 87:1996;3384-3394.
42. Haussler M.R., Whitfield G.K., Haussler C.A., Hsieh J.C., Thompson P.D., Selznick S.H., Dominguez C.E., Jurutka P.W. The nuclear vitamin D receptor: biological and molecular regulatory properties revealed. J. Bone Miner Res. 13:1998;325-349.
43. 3 indicates that the 6-s-cis conformation is preferred for rapid nongenomic biological responses and that neither 6-s-cis- nor 6-s-trans-locked analogs are preferred for genomic biological responses. Mol. Endocrinol. 11:1997;1518-1531.
44. 3 of whole cell chloride currents in osteoblastic ROS 17/2.8 cells. A structure-function study. J. Biol. Chem. 272:1997;22617-22622.
45. 3 in promyelocytic NB4 leukemia cells: a structure-function study. Endocrinology. 139:1998;457-465.
46. 3-induced differentiation of human leukemia HL60 cells. Exp. Cell Res. 258:2000;425-437.
47. Chapman D.E., Holbrook D.J., Chaney S.G., Hall I.H., Lee K.H. In vivo and in vitro effects of helenalin on mouse hepatic microsomal cytochrome P450. Biochem. Pharmacol. 41:1991;229-235.
48. Nagai F., Hiyoshi Y., Sugimachi K., Tamura H.O. Cytochrome P450 (CYP) expression in human myeloblastic and lymphoid cell lines. Biol. Pharm. Bull. 25:2002;383-385.
49. Gruebele A., Zawaski K., Kaplan D., Novak R.F. Cytochrome P450E1- and cytochrome P4502B1/2B2-catalyzed carbon tetrachloride metabolism: effects on signal transduction as demonstrated by altered immediate-early (c-fos and c-jun) gene expression and nuclear AP-1 and NF-κB transcription factor levels. Drug Metab. Dispos. 24:1996;15-22.
50. Puga A., Barnes S.J., Chang C., Zhu H., Nephew K.P., Khan S.A., Shertzer H.G. Activation of transcription factors activator protein-1 and nuclear factor-κB by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Biochem. Pharmacol. 59:2000;997-1005.
51. 3 and skin diseases. Arch Dermatol. Res. 284:1992;30-36.
52. Negri E., La Vecchia C., Franceschi S., D'Avanzo B., Parazzini F. Vegetable and fruit consumption and cancer risk. Int. J. Cancer. 48:1991;350-354.